Deal Flow
Letter · prints on one page
Transaction tear sheetData as of Nov 7, 2026
M&A · Industrials · Services-Help Supply Services

Knox Lane to acquire Cross Country Healthcare Inc

Announced May 6, 2026 · Closed Jul 28, 2026

Deal value$437M
Premium31.0%To unaffected price
EV / Adj. EBITDA—
ConsiderationAll cash$13.25 per share

Transaction

Acquirer
Knox Lane
Target
Cross Country Healthcare Inc (CCRN)
Buyer type
Strategic
Offer price per share
$13.25
Enterprise value
—
Status
Closed Jul 28, 2026

Deal protections

Break fee (target pays)
$14.2M · 3.3%
Reverse fee (buyer pays)
$14.2M · 3.3%
Go-shop
No-shop
Financing
No financing condition

Advisors

To the acquirer
MTS Health Partners
To the target
BofA Securities
BofA Securities fee
$6.1M

Sector context · Industrials

Comparable deals
98 in the prior 24 months
Premium
31.0% vs. 34.0% sector median
EV / Adj. EBITDA
Sector median 11.0x
Break fee
3.3% vs. 2.7% sector median

Timeline

  1. AnnouncedMay 6, 2026
  2. Proxy filedJun 3, 2026
  3. Definitive proxyJun 15, 2026
  4. Shareholder voteJul 16, 2026
  5. ClosedJul 21, 2026

Valuation · fairness opinions

Trading comparables$8.35$11.15
Precedent transactions$7.40$8.60
Precedent transactions$9.25$10.90
Discounted cash flow$11.55$16.30
Analyst price targets$9.09$13.64
Offer $13.25

Implied value per Cross Country Healthcare Inc share by analysis, from BofA Securities · DCF discount rate 9%–11%.

Sources
  • 8-K (EX-99) · May 7, 2026
  • DEFA14A (EX-99.1) · May 7, 2026
  • 8-K · May 7, 2026
  • 8-K (EX-99.1) · Jul 28, 2026

Adj. EBITDA is operating income + D&A + impairment, restructuring, deal costs and stock compensation, less any large gain on a sale, last twelve months, from the target's filings. Calculated by Castle, so it can differ from a bank's adjusted figure.

Prepared with Castle from public SEC EDGAR filings. Figures are extracted automatically; verify against the source documents. Not investment advice.